Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luis Fernando Mayorga Ayala"'
Autor:
Ester Navarro-Correal, Natalia Borruel, Virginia Robles, Claudia Herrera-de Guise, Luis Fernando Mayorga Ayala, Zahira Pérez Martínez, Arantxa Ibarz Casas, Sandra Agustino Rodríguez, Irene Joana Batuecas Duelt, Jorge García Alcaide, Sara López Branchadell, Esperanza Zuriguel-Perez, Francesc Casellas
Publikováno v:
Gastroenterología y Hepatología (English Edition)
Objective To report the impact of the COVID-19 pandemic on the activity of nurses working on an inflammatory bowel disease (IBD) unit and to identify reasons for telehealth care and its relationship to certain characteristics. Background The COVID-19
Autor:
Irene Joana Batuecas Duelt, sara López Branchadell, Jorge García Alcaide, Natalia Borruel, V. Robles, Ester Navarro-Correal, Zahira Pérez Martínez, Arantxa Ibarz Casas, Luis Fernando Mayorga Ayala, Sandra Agustino Rodríguez, Esperanza Zuriguel-Pérez, Francesc Casellas, Claudia Herrera-de Guise
Publikováno v:
Gastroenterologia Y Hepatologia
Gastroenterología y Hepatología
Gastroenterología y Hepatología
Objective To report the impact of the COVID-19 pandemic on the activity of nurses working on an inflammatory bowel disease (IBD) unit and to identify reasons for telehealth care and its relationship to certain characteristics. Background The COVID-19
Autor:
Claudia Herrera-de Guise, Luis Fernando Mayorga Ayala, Xavier Serra Ruiz, Virginia Robles Alonso, Natalia Borruel Sainz, Arantxa Ibarz, Zahira Pérez Martínez, Francesc Casellas
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
Inflammatory bowel disease affects many aspects of a patient's life and impairs their health-related quality of life (HRQoL). The COVID-19 outbreak has led to important mobility restrictions and a dramatic re-adjustment of social habits and health sy
Autor:
Claudia Herrera de Guise, Virginia Robles Alonso, Miquel Marquès Camí, Natalia Borruel Sainz, Francesc Casellas Jordá, Luis Fernando Mayorga Ayala
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 113(5)
Background and aim: ustekinumab is a fully human monoclonal antibody against IL-12/23, approved for induction and maintenance treatment of Crohn’s disease (CD). Real-life data shows its true effectiveness in terms of clinical and endoscopic respons